NCT04785287 2026-03-03Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesM.D. Anderson Cancer CenterPhase 1/2 Terminated13 enrolled
NCT04008797 2026-02-27A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorEisai Inc.Phase 1/2 Active not recruiting301 enrolled
NCT05438420 2026-02-24Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsQurient Co., Ltd.Phase 1/2 Active not recruiting120 enrolled
NCT06608940 2026-02-19BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular CarcinomaCase Comprehensive Cancer CenterPhase 1/2 Withdrawn